These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 739610)

  • 1. [Problems in urokinase therapy in cerebral infarction].
    Matsuo T; Matsuo O
    Rinsho Ketsueki; 1978 Oct; 19(10):1475-8. PubMed ID: 739610
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on blood coagulation and fibrinolytic activities in the cases of cerebral infarction treated with urokinase. 2nd Report -- espeically changes of coagulofibrinolytic system before and after UK infusion (author's transl)].
    Fujita S; Shou T; Yamamoto H; Ishikawa H; Itoga T
    Rinsho Ketsueki; 1979 Jul; 20(7):745-53. PubMed ID: 501999
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on blood coagulation and fibrinolytic activities in the three cases of cerebral infarction treated with urokinase. 1st report--120,000 I.U. administrated-- (author's transl)].
    Fujita S; Itoga T; Shou T; Yamamoto H; Ishikawa H
    Rinsho Ketsueki; 1978 Jun; 19(6):850-8. PubMed ID: 713046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urokinase, an expensive false development of thrombolytic therapy].
    von Kaulla KN
    Dtsch Med Wochenschr; 1976 Oct; 101(42):1543-5. PubMed ID: 976121
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the hypotensive action of urokinase beneficial for thrombolytic therapy?
    Matsuo O; Kosugi T; Mihara H
    Thromb Haemost; 1978 Apr; 39(2):526-7. PubMed ID: 580999
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrospective study on the efficacy of using urokinase therapy.
    Matsuo O; Kosugi T; Mihara H; Ohki Y; Matsuo T
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):684-8. PubMed ID: 506651
    [No Abstract]   [Full Text] [Related]  

  • 7. Lytic therapy in vitreous haemorrhage.
    Forrester JV; Williamson J
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):583-6. PubMed ID: 4534194
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombolytic therapy of acute ischemic cerebrovascular diseases].
    Gao S; Cui LY
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):137-8. PubMed ID: 15774228
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental and clinical studies on thrombolytic therapy with urokinase.
    Shiba T; Igarashi M; Takeuchi S; Awazu S; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):771-81. PubMed ID: 82362
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombolytic treatment of deep leg and pelvic vein thromboses].
    Breddin HK; Krzywanek HJ
    Internist (Berl); 1982 Jul; 23(7):410-6. PubMed ID: 7050003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment by urokinase of myocardial infarction and threatened infarction. Randomised study of 120 cases].
    Brochier M; Raynaud R; Planiol T; Fauchier JP; Griguer P; Archambaud D; Pellois A; Clisson M
    Arch Mal Coeur Vaiss; 1975 Jun; 68(6):563-9. PubMed ID: 810098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new "wonder" drug to dissolve clots. The results of urokinase therapy in acute myocardial infarction, pulmonary embolism and deep vein thrombosis.
    Mazel MS; Riera R; Levine ER
    Med Trial Tech Q; 1975; 22(1):52-67. PubMed ID: 1165704
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism.
    Marder VJ; Donahoe JF; Bell WR; Cranley JJ; Kwaan HC; Sashara AA; Barlow GH
    J Lab Clin Med; 1978 Nov; 92(5):721-9. PubMed ID: 712206
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study of fibrinolytic therapy in glomerulonephritis and nephrotic syndrome. III. Indication, time to start therapy and criteria of effect (author's transl)].
    Sato M; Nakazora H; Ohfuji T
    Nihon Jinzo Gakkai Shi; 1977 Sep; 19(9):717-31. PubMed ID: 599731
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Thrombolytic therapy of deep venous thromboses with urokinase.
    Theiss W; Kriessmann A; Wirtzfeld A
    Thromb Diath Haemorrh; 1975 Nov; 34(2):568-9. PubMed ID: 1198453
    [No Abstract]   [Full Text] [Related]  

  • 16. [The fibrinolytic therapy in renal disease (author's transl)].
    Kaburagi T; Yokoyama S; Tanaka K; Haniu T; Suzuki T; Mithunami K; Takayama S; Oguma S; Hatori T; Kishimoto T; Tomimoto K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Ischemic heart disease and plasma fibrinolytic activity. (4). Fibrinolytic enzyme therapy in acute myocardial infarct].
    Sasa H; Mizuguchi K; Futenma S; Nakamura S; Ito K
    Jpn Circ J; 1975 Jul; 39(7):887. PubMed ID: 1160115
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems in measuring the activity of alpha 2-plasmin inhibitor in the urokinase therapy].
    Moriyama H; Minami S; Okamoto K; Tsuchiya T; Tsuji K; Higashi T
    Rinsho Byori; 1987 Apr; 35(4):465-7. PubMed ID: 3613164
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of sclerosis treatment based on blood circulation or vascular lesions].
    Takeda K; Shigemi F; Shiraishi S; Nagai T; Kuwabara A
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):778-81. PubMed ID: 304924
    [No Abstract]   [Full Text] [Related]  

  • 20. [Massive pulmonary thromboembolism. Thrombolytic therapy with urokinase: proposed common protocol].
    Schivazappa L; Russo R; Charmet AP; Prandoni P; Compostella L; Crociani P
    Boll Soc Ital Cardiol; 1980; 25(6):551-5. PubMed ID: 7025862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.